about
Leishmanicidal activities of novel methylseleno-imidocarbamatesAntioxidant-prooxidant properties of a new organoselenium compound library.Novel library of selenocompounds as kinase modulators.Library of Seleno-Compounds as Novel Agents against Leishmania Species.Kinase regulation by sulfur and selenium containing compounds.Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.Novel Methylselenoesters as Antiproliferative Agents.Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1.Topological and quantum molecular descriptors as effective tools for analyzing cytotoxic activity achieved by a series of (diselanediyldibenzene-4,1-diylnide)biscarbamate derivatives.Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents.Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates.Molecular descriptors calculation as a tool in the analysis of the antileishmanial activity achieved by two series of diselenide derivatives. An insight into its potential action mechanism.Synthesis and antiproliferative activity of novel selenoester derivatives.A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells.Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitro.Selenocyanates and diselenides: a new class of potent antileishmanial agents.Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.Synthesis and in vitro anticancer activities of some selenadiazole derivatives.Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates.Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents.Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds.A diphenyldiselenide derivative induces autophagy via JNK in HTB-54 lung cancer cells.Combined Acylselenourea-Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators.Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma TherapeuticStructure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture.Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell linesActivity enhancement of selective antitumoral selenodiazoles formulated with poloxamine micellesMethylselenol release as a cytotoxic tool: a study of the mechanism of the activity achieved by two series of methylselenocarbamate derivativesNovel selenadiazole derivatives as selective antitumor and radical scavenging agentsSynthesis and Leishmanicidal Activity of Novel Urea, Thiourea, and Selenourea Derivatives of DiselenidesOrganoseleno cytostatic derivatives: Autophagic cell death with AMPK and JNK activationNovel N,N'-Disubstituted Acylselenoureas as Potential Antioxidant and Cytotoxic AgentsLeishmanicidal Activity of Isoselenocyanate Derivatives
P50
Q30389497-73409998-3667-499B-954B-A023526B560CQ33725230-6B26FF38-182B-4C4A-93B2-3F3D5C8D814FQ33973521-C3772EE1-8C84-4273-8AB2-911370514D4EQ36315604-70C18294-F0A3-40AF-BFDE-8C701EE03F51Q37852056-6E58C2FF-A998-4CD7-80B2-ACC9DD4D8E9EQ38029744-A086FF03-CC12-454C-BD64-34C8C82DB841Q38182637-80E1D147-C251-4B5E-99BC-55082BF14FD4Q38695892-4AFC4F77-CD35-4E96-BEB0-44FE3E038385Q38709385-557EA2BD-9783-4E0B-89E6-78DB7D2784FCQ38714887-95BF1A1B-4F67-44D1-967D-FB149EEA6A44Q38754029-09F5AF96-7A7B-44FB-8400-D131B1CFC65DQ38805128-4BE158AF-C420-46A0-9A5C-124E1BF89D7FQ38891993-A4BA6E48-BAF3-425B-A709-86667408B55AQ38897268-98D67B9B-8279-41E5-ACBC-D61DE750A4E3Q39007630-E9ABC15B-D906-4A37-8B8E-B0F8A91DA3B1Q39037400-0B6B2F65-C8D9-4198-8352-44DF6291CB02Q39267955-B3BD41E8-AA27-4A6D-8766-EC781548FA08Q39439301-11A2F953-2C90-437E-9918-6BB85EA7BB3DQ39542573-6A108621-8671-4F8A-BCD4-095CE2777D8DQ39626275-9FB2EB82-9A48-4912-83D9-45D1E3CBEF65Q39626985-A741B7F8-E574-45A3-96F0-7957D26E3639Q39648084-C2D2C619-8690-421B-AD7B-E0A0C3063B01Q39794596-1A7ABA32-8861-48ED-AFC9-2E367207D09AQ41595418-4C02704E-1C5B-4A44-A729-BCA0E9277509Q41911935-D18309A6-F786-476F-9581-2956B4F66313Q52579089-E2B2781D-36C9-4EBD-A336-F7A59D526F3AQ64273467-128FD197-ED8D-440A-BB85-71A6EB7346FAQ64943456-1E2CC3A5-4627-4D20-AF41-15A989824DF9Q87383365-06364BF7-5A93-4154-AD1E-6E929DC34335Q89362571-EF4FA6A6-BD33-41B5-B18C-C6FAD84C920AQ90653939-8B885436-6C0C-4E48-AFA7-3C3B26F20045Q90714664-3DCFA364-1F8E-40B7-B282-E846194DD2FAQ91726449-31DEDFB1-7DFC-4C49-A346-C6EA79B5F09CQ91977384-69C75D10-3D98-4F6D-AC91-2F3C9E5FF9EAQ92632900-AD5C6053-E277-4078-B538-8546AB1DAD2DQ93380725-1BF556DC-9AC8-4837-9436-4D1192926D92
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Plano
@ast
Daniel Plano
@en
Daniel Plano
@es
Daniel Plano
@nl
Daniel Plano
@sl
type
label
Daniel Plano
@ast
Daniel Plano
@en
Daniel Plano
@es
Daniel Plano
@nl
Daniel Plano
@sl
prefLabel
Daniel Plano
@ast
Daniel Plano
@en
Daniel Plano
@es
Daniel Plano
@nl
Daniel Plano
@sl
P106
P1153
22980649300
P21
P31
P496
0000-0002-8266-0445